Reframing Filler-Induced Alopecia: Recognizing Pressure Alopecia as a Distinct Mechanism in Injectable Complications

The document discusses a study that reclassifies pressure alopecias (PAs), specifically identifying Type 2 PA as a distinct mechanism of hair loss associated with injectable treatments. This type of alopecia results from the compression of blood vessels by injected substances, leading to ischemia and inflammation that disrupt hair follicle homeostasis and the anagen phase, causing hair loss. The study emphasizes the importance of recognizing these causes as mechanical rather than procedural errors, which can inform more targeted preventive measures and treatment strategies. The findings have implications for drug development, clinical practice, and research, highlighting the need to consider variables such as filler volume, injection pressure, and anatomical differences in risk assessments. This approach not only aids in managing filler-induced alopecia but also extends to other forms of injection-related hair loss.